Belite Bio (BLTE) Current Leases (2022 - 2025)

Belite Bio's quarterly Current Leases came in at $241000.0 in Q4 2025, down 12.68% year-on-year from $276000.0 in Q4 2024, and down 12.68% quarter-over-quarter from $276000.0 in Q4 2024.

Belite Bio has reported Current Leases for 4 years, with the latest figure at $241000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 12.68% year-over-year to $241000.0; the trailing twelve-month figure through Dec 2025 stood at $241000.0 (down 12.68% YoY), and the FY2025 full-year result was $241000.0, down 12.68% from the prior year.
  • Current Leases for Q4 2025 stood at $241000.0, down from $276000.0 in the prior quarter.
  • The five-year high for Current Leases was $308000.0 in Q4 2023, with the low at $198000.0 in Q4 2022.
  • Average Current Leases over 4 years is $255750.0, with a median of $258500.0 recorded in 2024.
  • Year-over-year, Current Leases jumped 55.56% in 2023 and slipped 12.68% in 2025.
  • Tracing BLTE's Current Leases over 4 years: stood at $198000.0 in 2022, then jumped by 55.56% to $308000.0 in 2023, then decreased by 10.39% to $276000.0 in 2024, then fell by 12.68% to $241000.0 in 2025.
  • The last three Current Leases figures came in at $241000.0 (Q4 2025), $276000.0 (Q4 2024), and $308000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Belite Bio 4.92 Bn 4.45 Bn - 241,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 241,000.00
Sep 30, 2025 265,000.00
Dec 31, 2024 276,000.00
Dec 31, 2023 308,000.00
Dec 31, 2022 198,000.00